Endothelial Facilitation in Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Simvastatin

Simvastatin, 40 mg per day orally

DRUG

L-Arginine

L-Arginine, 2 Gm four times per day orally;

DRUG

Tetrahydrobiopterin

Tetrahydrobiopterin 20 mg/kg/day orally

Trial Locations (1)

01655

UMass Medical School/ UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

The Glass Foundation

UNKNOWN

lead

University of Massachusetts, Worcester

OTHER

NCT01439555 - Endothelial Facilitation in Alzheimer's Disease | Biotech Hunter | Biotech Hunter